Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011, Article ID 245738, 8 pages
http://dx.doi.org/10.1155/2011/245738
Review Article

Approach to the Pretransplant Evaluation of the Living Kidney Donor

1Division of Kidney Diseases and Hypertension, Department of Medicine, Hofstra North Shore-LIJ School of Medicine, Great Neck, NY 11021, USA
2Department of Surgery, Hofstra North Shore-LIJ School of Medicine, Manhasset, NY 11030, USA

Received 30 September 2011; Accepted 4 November 2011

Academic Editor: Gian Luigi Adani

Copyright © 2011 Mala Sachdeva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Organ Procurement and Transplantation Network, “National data,” 2011, http://optn.transplant.hrsa.gov/latestData/step2.asp.
  2. P. C. T. Pham, A. H. Wilkinson, and P. T. T. Pham, “Evaluation of the potential living kidney donor,” American Journal of Kidney Diseases, vol. 50, no. 6, pp. 1043–1051, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. American Diabetic Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010. View at Google Scholar
  4. C. B. Vigneault, W. S. Asch, N. K. Dahl, and M. J. Bia, “Should living kidney donor candidates with impaired fasting glucose donate?” Clinical Journal of the American Society of Nephrology, vol. 6, no. 8, pp. 2054–2059, 2011. View at Publisher · View at Google Scholar · View at PubMed
  5. D. A. Mandelbrot, M. Pavlakis, G. M. Danovitch et al., “The medical evaluation of living kidney donors: a survey of US transplant centers,” American Journal of Transplantation, vol. 7, no. 10, pp. 2333–2343, 2007. View at Publisher · View at Google Scholar · View at PubMed
  6. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” Hypertension, vol. 42, no. 6, pp. 1206–1252, 2003. View at Publisher · View at Google Scholar · View at PubMed
  7. K. L. Lentine, M. A. Schnitzler, H. Xiao et al., “Racial variation in medical outcomes among living kidney donors,” New England Journal of Medicine, vol. 363, no. 8, pp. 724–732, 2010. View at Publisher · View at Google Scholar · View at PubMed
  8. N. Y. Wang, J. H. Young, L. A. Meoni, D. E. Ford, T. P. Erlinger, and M. J. Klag, “Blood pressure change and risk of hypertension associated with parental hypertension: the Johns Hopkins precursors study,” Archives of Internal Medicine, vol. 168, no. 6, pp. 643–648, 2008. View at Publisher · View at Google Scholar · View at PubMed
  9. M. D. Rizzari, T. M. Suszynski, K. J. Gillingham, and A. J. Matas, “Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors,” Transplantation, vol. 92, no. 1, pp. 70–75, 2011. View at Publisher · View at Google Scholar · View at PubMed
  10. G. Nyberg, L. Hedman, I. Blohme, and C. Svalander, “Morphologic findings in baseline kidney biopsies from living related donors,” Transplantation Proceedings, vol. 24, no. 1, pp. 355–356, 1992. View at Google Scholar
  11. M. J. Bia, E. L. Ramos, G. M. Danovitch et al., “Evaluation of living renal donors: the current practice of us transplant centers,” Transplantation, vol. 60, no. 4, pp. 322–327, 1995. View at Google Scholar
  12. F. L. Delmonico, “Consensus statement on the live organ donor,” Journal of the American Medical Association, vol. 284, no. 22, pp. 2919–2926, 2000. View at Google Scholar
  13. B. L. Kasiske, M. Ravenscraft, E. L. Ramos, R. S. Gaston, M. J. Bia, and G. M. Danovitch, “The evaluation of living renal transplant donors: clinical practice guidelines,” Journal of the American Society of Nephrology, vol. 7, no. 11, pp. 2288–2313, 1996. View at Google Scholar
  14. H. N. Ibrahim, S. K. Akkina, E. Leister et al., “Pregnancy outcomes after kidney donation,” American Journal of Transplantation, vol. 9, no. 4, pp. 825–834, 2009. View at Publisher · View at Google Scholar
  15. A. V. Reisæter, J. Røislien, T. Henriksen, L. M. Irgens, and A. Hartmann, “Pregnancy and birth after kidney donation: the Norwegian experience,” American Journal of Transplantation, vol. 9, no. 4, pp. 820–824, 2009. View at Publisher · View at Google Scholar · View at PubMed
  16. F. L. Delmonico, “A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines,” Transplantation, vol. 79, no. 6, pp. S53–S66, 2005. View at Publisher · View at Google Scholar
  17. I. F. Nevis and A. X. Garg, “Donor nephrectomy outcomes research (DONOR) network,” American Journal of Transplantation, vol. 9, pp. 661–668, 2009. View at Google Scholar
  18. E. Mancilla, C. Avila-Casado, N. Uribe-Uribe et al., “Time-zero renal biopsy in living kidney transplantation: a valuable opportunity to correlate predonation clinical data with histological abnormalities,” Transplantation, vol. 86, no. 12, pp. 1684–1688, 2008. View at Publisher · View at Google Scholar · View at PubMed
  19. J. Kahu, L. Kyllönen, A. Räisänen-Sokolowski, and K. Salmela, “Donor risk score and baseline biopsy CADI value predict kidney graft outcome,” Clinical Transplantation, vol. 25, no. 3, pp. E276–E283, 2011. View at Publisher · View at Google Scholar · View at PubMed
  20. C. L. Davis, “Living kidney donors: current state of affairs,” Advances in Chronic Kidney Disease, vol. 16, no. 4, pp. 242–249, 2009. View at Publisher · View at Google Scholar · View at PubMed
  21. J. Uribarri, M. S. Oh, and H. J. Carroll, “The first kidney stone,” Annals of Internal Medicine, vol. 111, no. 12, pp. 1006–1009, 1989. View at Google Scholar
  22. C. Y. Hsu, C. E. McCulloch, C. Iribarren, J. Darbinian, and A. S. Go, “Body mass index and risk for end-stage renal disease,” Annals of Internal Medicine, vol. 144, no. 1, pp. 21–28, 2006. View at Google Scholar
  23. I. Maeda, T. Hayashi, K. K. Sato et al., “Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 10, pp. 2462–2469, 2011. View at Publisher · View at Google Scholar · View at PubMed
  24. H. N. Ibrahim, R. Foley, L. Tan et al., “Long-term consequences of kidney donation,” New England Journal of Medicine, vol. 360, no. 5, pp. 459–469, 2009. View at Publisher · View at Google Scholar · View at PubMed
  25. CDC, “Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs,” Morbidity and Mortality Weekly Report, vol. 43, no. RR-8, pp. 1–26, 1994. View at Google Scholar
  26. Organ Procurement and Transplantation Network, “Identification of transmissible diseases in organ recipients,” 2010, http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_16.pdf.
  27. L. M. Kucirka, C. Alexander, R. Namuyinga, C. Hanrahan, R. A. Montgomery, and D. L. Segev, “Viral Nucleic Acid Testing (NAT) and OPO-level disposition of high-risk donor organs,” American Journal of Transplantation, vol. 9, no. 3, pp. 620–628, 2009. View at Publisher · View at Google Scholar · View at PubMed
  28. K. Sterner, N. Zelikovsky, C. Green, and B. S. Kaplan, “Psychosocial evaluation of candidates for living related kidney donation,” Pediatric Nephrology, vol. 21, no. 10, pp. 1357–1363, 2006. View at Publisher · View at Google Scholar · View at PubMed
  29. R. J. Leo, B. A. Smith, and D. L. Mori, “Guidelines for conducting a psychiatric evaluation of the unrelated kidney donor,” Psychosomatics, vol. 44, no. 6, pp. 452–460, 2003. View at Publisher · View at Google Scholar
  30. S. A. Fischer and R. K. Avery, “Screening of donor and recipient prior to solid organ transplantation,” American Journal of Transplantation, vol. 9, no. 4, pp. S7–S18, 2009. View at Publisher · View at Google Scholar · View at PubMed
  31. B. D. Shames, A. M. D'Alessandro, and H. W. Sollinger, “Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy?” American Journal of Transplantation, vol. 2, no. 7, pp. 658–663, 2002. View at Publisher · View at Google Scholar
  32. US Preventative Service Website, 2011, http://www.uspreventiveservicestaskforce.org/adultrec.htm#cancer.
  33. M. A. Nalesnik, E. S. Woodle, J. M. Dimaio et al., “Donor-transmitted malignancies in organ transplantation: assessment of clinical risk,” American Journal of Transplantation, vol. 11, no. 6, pp. 1140–1147, 2011. View at Publisher · View at Google Scholar · View at PubMed
  34. C. J. E. Watson and J. A. Bradley, “Evaluating the risk of cancer transmission to optimize organ usage,” American Journal of Transplantation, vol. 11, no. 6, pp. 1113–1114, 2011. View at Publisher · View at Google Scholar · View at PubMed
  35. I. Penn, “Transmission of cancer from organ donors,” Annals of Transplantation, vol. 2, no. 4, pp. 7–12, 1997. View at Google Scholar